sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large...

div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: sitesutorontocasitesutorontocaacdclabpubsPM23241603pdf · To date only CA125 a large mucin-type glycoprotein is widely used as an ovarian cancer biomarker in the clinical src=https:reader035fdocumentsusreader035viewer20220711025fdb99100fb4750da623b45dhtml5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: sitesutorontocasitesutorontocaacdclabpubsPM23241603pdf · To date only CA125 a large mucin-type glycoprotein is widely used as an ovarian cancer biomarker in the clinical src=https:reader035fdocumentsusreader035viewer20220711025fdb99100fb4750da623b45dhtml5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: sitesutorontocasitesutorontocaacdclabpubsPM23241603pdf · To date only CA125 a large mucin-type glycoprotein is widely used as an ovarian cancer biomarker in the clinical src=https:reader035fdocumentsusreader035viewer20220711025fdb99100fb4750da623b45dhtml5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: sitesutorontocasitesutorontocaacdclabpubsPM23241603pdf · To date only CA125 a large mucin-type glycoprotein is widely used as an ovarian cancer biomarker in the clinical src=https:reader035fdocumentsusreader035viewer20220711025fdb99100fb4750da623b45dhtml5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: sitesutorontocasitesutorontocaacdclabpubsPM23241603pdf · To date only CA125 a large mucin-type glycoprotein is widely used as an ovarian cancer biomarker in the clinical...

sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large...

Documents

Transcript of sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large...

Second Edition - A - Z Directory | University of Torontosites.utoronto.ca/acdclab/pubs/PM/19763436.pdfSecond Edition For further volumes: Cancer Treatment and Research Steven T. Rosen,

CA125: More than Just a Biomarker Manish S. Patankar, PhD University of Wisconsin-Madison Department of OB/GYN Division of Gynecologic Oncology.

Molecular Alterations during ... - University of Torontosites.utoronto.ca/acdclab/pubs/PM/21956922.pdf · Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON,

spiral.imperial.ac.uk · Web viewTitle: Predicting circulating CA125 levels among healthy premenopausal women. Authors and affiliations: Naoko Sasamoto1,2, Ana Babic,2,3 Bernard

Strategies for discovering novel cancer biomarkers through ...sites.utoronto.ca/acdclab/pubs/PM/18695711.pdf · Strategies for discovering novel cancer biomarkers through utilization

Clinical Utility of CA125 Levels Predicting Confirmed ...downloads.hindawi.com/journals/idog/1998/891484.pdfadnexitis; laboratory diagnosis; tumormakers he glycoprotein CA125, a cell

Programmable Bio-Nano-Chip Systems for Serum CA125 ...€¦ · (Programmable) platform for CA125 serum quantitation, a biomarker prominently implicated in multi-modal and multi-marker

Can Replacing CA125 with HE4 in Risk of Malignancy Indices ...downloads.hindawi.com/journals/bmri/2017/6712376.pdf · 2 BioMedResearchInternational sensitivity for detecting ovarian

Androgens act synergistically to enhance estrogen-induced …sites.utoronto.ca/acdclab/pubs/PM/19383315.pdf · 2009. 11. 6. · Androgens act synergistically to enhance estrogen-induced

1 Highly accurate detection of ovarian cancer using CA125 …1 1 Highly accurate detection of ovarian cancer using CA125 but limited improvement 2 with serum MALDI-TOF MS profiling

Kallikrein-Related Peptidase 14 Acts on ... - utoronto.casites.utoronto.ca/acdclab/pubs/PM/21907696.pdf · for activating PARs in colon cancer remain unknown. Extensive literature

Cancer secretomics reveal pathophysiological pathways in cancer molecular …sites.utoronto.ca/acdclab/pubs/PM/20934395.pdf · 2013. 7. 5. · Review Cancer secretomics reveal pathophysiological

Mass Spectrometry: Uncovering the Cancer Proteome for ...sites.utoronto.ca/acdclab/pubs/PM/17161675.pdfamong clinicians and laboratory medicine specialists. This is reﬂected in practice

QUICK REFERENCE GUIDE - Forza Montacargasforzamontacargas.com/assets/lpg_sypnlpgqrg.pdf · 5 IMPCO CA125 Series - CA125 IMPCA125-094 Carburetor Assembly IMPCA125-100-2 Carburetor

خيرازنا حشيغنا rzoke.pdf · 2017. 6. 11. · Molecular characterization of CA125 in benign & Biology 2004 malignant in ovarian tumors using immunoradiometric assay techniques.

Platform for Establishing Interlaboratory …sites.utoronto.ca/acdclab/pubs/PM/20945832.pdfassays for proteins and for sharing and implementing such assays in routine practices for

Yijing Yu, Ioannis Prassas and Eleftherios P. …sites.utoronto.ca/acdclab/pubs/PM/24854536.pdf · Yijing Yu: Department of Laboratory Medicine and Pathobiology, University of Toronto,

The cancer antigen CA125 represents a novel counter receptor for

NEWSLETTER - sites.utoronto.casites.utoronto.ca/icm/vol01no2.pdf · By 1999 the 25-volume anthology had been completed, with professionally edited scores of some 1500 works composed

A comparison between serum levels of interleukin-6 and CA125 in ...